Guided Therapeutics Inc.

5835 Peachtree Corners East, Suite B

Norcross, Georgia 30092

 

December 2, 2022

 

VIA EDGAR

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, NE

Washington, D.C. 20549

 

 

Re:

Guided Therapeutics Inc.

 

 

Request for Withdrawal Pursuant to Rule 477 of Registration Statement on Form S-1

(File No. 333-259871)

 

Ladies and Gentleman:

 

Pursuant to Rule 477 under the Securities Act of 1933, as amended, on behalf of Guided Therapeutics Inc. (“we,” “us,” “our,” or the “Company”), we hereby submit this letter to notify the Securities and Exchange Commission (the “SEC”) of our withdrawal of our Registration Statement on Form S-1 (File No. 333-259871) (the “Registration Statement”), because the Company has elected to abandon the transactions subject thereto. The Registration Statement was not declared effective and no securities have been issued or sold under the Registration Statement.

 

Thank you for your assistance with this matter. If you have any questions or comments concerning this request, please call our legal counsel, Robert F. Charron, Esq. of Ellenoff Grossman & Schole LLP, at (212) 370-1300.

 

 

Sincerely,

 

 

 

 

 

/s/ Gene Cartwright

 

 

Gene Cartwright

 

 

President and Chief Executive Officer

 

 

Grafico Azioni Guided Therapeutics (QB) (USOTC:GTHP)
Storico
Da Feb 2025 a Mar 2025 Clicca qui per i Grafici di Guided Therapeutics (QB)
Grafico Azioni Guided Therapeutics (QB) (USOTC:GTHP)
Storico
Da Mar 2024 a Mar 2025 Clicca qui per i Grafici di Guided Therapeutics (QB)